Boothbay Fund Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Boothbay Fund Management's DGX Position: Q2 2026 in Review
Boothbay Fund Management sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 1,705 shares — an estimated $334K sold.
Boothbay Fund Management first reported a position in DGX in Q4 2016 and held it in 16 quarters. The position peaked at $701K in Q4 2025. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Boothbay Fund Management reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
- Boothbay Fund Management sold 1,705 Quest Diagnostics shares in Q2 2026, an estimated $334K.
- Boothbay Fund Management first reported a position in Quest Diagnostics in Q4 2016 and held it in 16 quarters.
- Boothbay Fund Management's Quest Diagnostics position peaked at $701K in Q4 2025.
- 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.